Our data showed that Andro could be a promising therapeutic lead against Al-induced neurotoxicity by regulating p62-mediated keap1-Nrf2 pathways, providing a basis for perfecting the mechanism of Andro in the treatment of AD. The gene discussed is SQSTM1; the disease is Alzheimer disease.